Page last updated: 2024-09-03

7 alpha-hydroxy-4-cholesten-3-one and ezetimibe

7 alpha-hydroxy-4-cholesten-3-one has been researched along with ezetimibe in 1 studies

Compound Research Comparison

Studies
(7 alpha-hydroxy-4-cholesten-3-one)
Trials
(7 alpha-hydroxy-4-cholesten-3-one)
Recent Studies (post-2010)
(7 alpha-hydroxy-4-cholesten-3-one)
Studies
(ezetimibe)
Trials
(ezetimibe)
Recent Studies (post-2010) (ezetimibe)
13428592,4845631,465

Protein Interaction Comparison

ProteinTaxonomy7 alpha-hydroxy-4-cholesten-3-one (IC50)ezetimibe (IC50)
NPC1-like intracellular cholesterol transporter 1Homo sapiens (human)0.37

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeBarber, AE; Jones, PJH; Mymin, D; Myrie, SB; Othman, RA; Roullet, JB; Steiner, RD1

Trials

1 trial(s) available for 7 alpha-hydroxy-4-cholesten-3-one and ezetimibe

ArticleYear
Thyroid Hormone Status in Sitosterolemia Is Modified by Ezetimibe.
    The Journal of pediatrics, 2017, Volume: 188

    Topics: Adolescent; Adult; Anticholesteremic Agents; Cholestanol; Cholestenones; Cholesterol; Ezetimibe; Female; Humans; Hypercholesterolemia; Intestinal Diseases; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Phytosterols; Sitosterols; Thyrotropin; Thyroxine; Triiodothyronine; Young Adult

2017